// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
The scale and speed of the global vaccine research and development effort in response to COVID-19
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr